The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st Line t...
Current Studies
Clinical trials advance medical treatment and therapy to increase survival and quality of life.
Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.
Successful treatments we know today are the result of past clinical trials.
Filter your results
By specialty
- Cardiology (1)
- COVID-19 (1)
- Gastroenterology (1)
- Genetics (1)
- Hematology (1)
- Neurovascular (1)
- Oncology/Cancer (20)
- Orthopedics (1)
- Pain Management (2)
- Pediatric Gastroenterology (1)
- Pulmonary (4)
- Radiation Therapy (10)
- Rheumatology (1)
- Urology (5)
By disease or condition
- Bladder Cancer (1)
- Breast Cancer (1)
- Cancer (10)
- Cancer Screening (2)
- Chronic Pain (2)
- COVID-19 (1)
- Erectile Dysfunction (1)
- Erosive Esophagitis (1)
- Hepatocellular Carcinoma (2)
- Ischemic Stroke (1)
- Leukemia (1)
- Lupus (SLE) (1)
- Male Overactive Bladder (1)
- Metastatic Colorectal Cancer (2)
- Multiple Myeloma (1)
- Non-Small Cell Lung Cancer (1)
- Oropharyngeal Cancer (2)
- Osteoarthritis (1)
- Prostate Cancer (4)
- Prostatectomy (1)
- Radiation Therapy (3)
- Ulcerative Colitis (1)
- Urinary Urge Incontinence (UUI) (2)
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab inCombination with Platinum-based Chemotherapy for the First-line Treatment of Patients with MetastaticNon-squamous Non-small Cell Lung Cancer Whose...
The purpose of ARTEMIDE-Lung03 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st L...
Screening for High Frequency Malignant Disease (SHIELD)
The SHIELD (Screening for High Frequency Malignant Disease) study is a prospective, observational, multi-site basket design trial without randomization. The primary objective of the study is to eva...
Screening for High Frequency Malignant Disease
The SHIELD (Screening for High Frequency Malignant Disease) study is a prospective, observational, multi-site basket design trial without randomization. The primary objective of the study is to eva...
